Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Hansjörg Rothe"'
Autor:
Joel T. Gibson, Omid Sadeghi-Alavijeh, Daniel P. Gale, Hansjörg Rothe, Genomics England Research Consortium, Judy Savige
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract X-linked Alport syndrome is a genetic kidney disease caused by pathogenic COL4A5 variants, but little is known of the consequences of missense variants affecting the NC1 domain of the corresponding collagen IV α5 chain. This study examined
Externí odkaz:
https://doaj.org/article/96c0043e8d0a42569e1be2e4cd114cf7
Autor:
Joel T. Gibson, Mary Huang, Marina Shenelli Croos Dabrera, Krushnam Shukla, Hansjörg Rothe, Pascale Hilbert, Constantinos Deltas, Helen Storey, Beata S. Lipska-Ziętkiewicz, Melanie M. Y. Chan, Omid Sadeghi-Alavijeh, Daniel P. Gale, Genomics England Research Consortium, Agne Cerkauskaite, Judy Savige
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Alport syndrome is the commonest inherited kidney disease and nearly half the pathogenic variants in the COL4A3–COL4A5 genes that cause Alport syndrome result in Gly substitutions. This study examined the molecular characteristics of Gly s
Externí odkaz:
https://doaj.org/article/864c1ed9fcad4e3fa88284e259fc2a5f
Autor:
Hansjörg Rothe, Vincent Brandenburg, Margot Haun, Barbara Kollerits, Florian Kronenberg, Markus Ketteler, Christoph Wanner
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0172407 (2017)
INTRODUCTION:Calciphylaxis/calcific uremic arteriolopathy affects mainly end-stage kidney disease patients but is also associated with malignant disorders such as myeloma, melanoma and breast cancer. Genetic risk factors of calciphylaxis have never b
Externí odkaz:
https://doaj.org/article/5adc4ac960bb4472989d229bd6bc2932
Autor:
Joel T, Gibson, Mary, Huang, Marina, Shenelli Croos Dabrera, Krushnam, Shukla, Hansjörg, Rothe, Pascale, Hilbert, Constantinos, Deltas, Helen, Storey, Beata S, Lipska-Ziętkiewicz, Melanie M Y, Chan, Omid, Sadeghi-Alavijeh, Daniel P, Gale, Agne, Cerkauskaite, M, Zarowiecki
Publikováno v:
Scientific reports. 12(1)
Alport syndrome is the commonest inherited kidney disease and nearly half the pathogenic variants in the COL4A3-COL4A5 genes that cause Alport syndrome result in Gly substitutions. This study examined the molecular characteristics of Gly substitution
Autor:
René Mauer, Patrick Arndt, Xina Grählert, Christian Hugo, Jan Sradnick, Torsten Siepmann, Hansjörg Rothe, Tom H. Lindner, Torsten Tonn, Holger Schirutschke, Torsten Langer, Leona Anders, Kerstin Barnett, Friederike Kessel, Petra Müller, Moritz Anft, Robert Faulhaber-Walter, Hannah Kröger, Kirsten Anding-Rost, Jan Hüther, Thilo Pluntke, Anne Steglich, Frank Meistring, Kerstin Frank, Thomas Stehr, Claudia Karger, Anna Klimova, Joachim Beige, Ingolf Bast, Katja Escher, Jens Schewe, Timm H. Westhoff, Jörg Schwöbel, Arturo Blazquez-Navarro, Harald Seidel, Nina Babel, Frank Pistrosch, Heike Martin, Annegret Pietzonka, Ulrik Stervbo, Alexander Paliege, Simon Cerny, Florian Gembardt, Julian Stumpf
Publikováno v:
The Lancet Regional Health. Europe
Background: Dialysis and kidney transplant patients are vulnerable populations for COVID-19 related disease and mortality. Methods: We conducted a prospective study exploring the eight week time course of specific cellular (interferon-I³ release ass
Publikováno v:
Nephrology Dialysis Transplantation. 29:1267-1270
Publikováno v:
Nature Reviews Nephrology. 7:509-516
Strong and unidirectional associations exist between the severity of cardiovascular calcifications and mortality in patients with advanced chronic kidney disease. In the past 10 years, a wealth of experimental and clinical information has been publis
Autor:
Hansjörg Rothe
Publikováno v:
Advances in Anthropology. :38-40
Certain historical events may be driven by anthropological topoi surfacing from layers below culture and society, once the structures of society and culture allow for that to happen. Difficulties in finding a suitable term to describe a historical ev
Autor:
Hansjörg Rothe
Publikováno v:
Clinical and Experimental Nephrology. 22:983-983
Publikováno v:
Personalized Medicine. 5:109-116
Aims: Calcimimetics are effective in reducing parathyroid hormone (PTH) levels in patients with secondary hyperparathyroidism, but variability in dose response has been noted. We examined SNP Arg990Gly of the calcium-sensing receptor as a possible ca